Source: WORLD JOURNAL OF HEPATOLOGY. Unidade: FM
Subjects: MODELOS ANIMAIS, NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR
ABNT
MICHALCZUK, Matheus Truccolo et al. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. WORLD JOURNAL OF HEPATOLOGY, v. 16, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58875. Acesso em: 09 nov. 2024.APA
Michalczuk, M. T., Longo, L., Keingeski, M. B., Basso, B. de S., Guerreiro, G. T. S., Ferrari, J. T., et al. (2024). Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. WORLD JOURNAL OF HEPATOLOGY, 16( 1). doi:10.4254/wjh.v16.i1.75NLM
Michalczuk MT, Longo L, Keingeski MB, Basso B de S, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CPMS de, Uribe-Cruz C, Cerski CTS. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease [Internet]. WORLD JOURNAL OF HEPATOLOGY. 2024 ; 16( 1):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58875Vancouver
Michalczuk MT, Longo L, Keingeski MB, Basso B de S, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CPMS de, Uribe-Cruz C, Cerski CTS. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease [Internet]. WORLD JOURNAL OF HEPATOLOGY. 2024 ; 16( 1):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58875